Genscript Biotech Reports 2021 Annual Results - Press Releas

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compared with appro

Related Keywords

China , Nanjing , Jiangsu , Patrick Liu , Genscript Probio , Revenue Of The Group , Genscript Biotech Corporation , Genscript Group , Reporting Period , Genscript Biotech , Legend Biotech , Four Business , Mainland China , Follow On Public Offering , Script Biotech ,